NL7317046A - - Google Patents

Info

Publication number
NL7317046A
NL7317046A NL7317046A NL7317046A NL7317046A NL 7317046 A NL7317046 A NL 7317046A NL 7317046 A NL7317046 A NL 7317046A NL 7317046 A NL7317046 A NL 7317046A NL 7317046 A NL7317046 A NL 7317046A
Authority
NL
Netherlands
Application number
NL7317046A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7317046A publication Critical patent/NL7317046A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
NL7317046A 1972-12-29 1973-12-12 NL7317046A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31994672A 1972-12-29 1972-12-29
US05/410,831 US4032521A (en) 1972-12-29 1973-11-08 Cephalosporin phosphonic acid, sulfonic acid and sulfonamide compounds

Publications (1)

Publication Number Publication Date
NL7317046A true NL7317046A (fr) 1974-07-02

Family

ID=26982211

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7317046A NL7317046A (fr) 1972-12-29 1973-12-12

Country Status (7)

Country Link
US (1) US4032521A (fr)
JP (1) JPS4994697A (fr)
CH (1) CH606000A5 (fr)
DE (1) DE2364735A1 (fr)
FR (1) FR2212138B1 (fr)
GB (1) GB1449290A (fr)
NL (1) NL7317046A (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
JPS5760345B2 (fr) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4117126A (en) * 1975-04-03 1978-09-26 Sumitomo Chemical Company, Ltd. 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4031077A (en) * 1975-10-06 1977-06-21 Pfizer Inc. Antibacterial 3-phosphono penams
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
US4109084A (en) * 1976-12-08 1978-08-22 E. R. Squibb & Sons, Inc. Thiooxime cephalosporin derivatives
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
IL86941A (en) * 1987-07-10 1993-07-08 Gist Brocades Nv Process for the preparation of cephem compounds and some new cephalosporin derivatives prepared by this process
US5731299A (en) * 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5470845A (en) * 1992-10-28 1995-11-28 Bristol-Myers Squibb Company Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
US5447922A (en) * 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
CN103635478A (zh) * 2011-04-28 2014-03-12 盐野义制药株式会社 具有儿茶酚或假儿茶酚结构的新颖头孢烯类化合物
JPWO2013002215A1 (ja) * 2011-06-27 2015-02-23 塩野義製薬株式会社 ピリジニウム基を有するセフェム化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA704468B (en) * 1969-07-08 1971-06-30 Ciba Ltd Process for the manufacture of amino compounds
US3856785A (en) * 1972-07-24 1974-12-24 Squibb & Sons Inc Cephalosporin esters
US3966719A (en) * 1973-10-17 1976-06-29 Pfizer Inc. 4-(Tetrazol-5-yl)-Δ3 -cephem compounds

Also Published As

Publication number Publication date
FR2212138A1 (fr) 1974-07-26
DE2364735A1 (de) 1974-07-04
GB1449290A (en) 1976-09-15
CH606000A5 (fr) 1978-10-13
FR2212138B1 (fr) 1976-05-14
US4032521A (en) 1977-06-28
JPS4994697A (fr) 1974-09-09

Similar Documents

Publication Publication Date Title
JPS4915755A (fr)
FR2176995A1 (fr)
FR2212138B1 (fr)
HU169395B (fr)
JPS4958724A (fr)
JPS4946725U (fr)
JPS4974493U (fr)
IN138248B (fr)
FR2184503B2 (fr)
JPS527612B2 (fr)
JPS4934283A (fr)
JPS4899082A (fr)
FR2171541A5 (fr)
JPS4940872U (fr)
JPS49102218U (fr)
CH576141A5 (fr)
CH578749A5 (fr)
CH578552A5 (fr)
CH578539A5 (fr)
CH578506A5 (fr)
CH577259A5 (fr)
CH577087A5 (fr)
CH494772A4 (fr)
CH575606A5 (fr)
CH575193A5 (fr)

Legal Events

Date Code Title Description
BV The patent application has lapsed